D.E. Shaw & Co’s Marinus Pharmaceuticals, Inc MRNS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-178,801
| Closed | -$315K | – | 3562 |
|
|
2024
Q3 | $315K | Buy |
+178,801
| New | +$315K | ﹤0.01% | 2668 |
|
|
2023
Q4 | – | Sell |
-11,400
| Closed | -$91.8K | – | 3419 |
|
|
2023
Q3 | $91.8K | Sell |
11,400
-343,348
| -97% | -$2.76M | ﹤0.01% | 2677 |
|
|
2023
Q2 | $3.85M | Buy |
354,748
+266,521
| +302% | +$2.89M | ﹤0.01% | 1387 |
|
|
2023
Q1 | $609K | Buy |
+88,227
| New | +$609K | ﹤0.01% | 2431 |
|
|
2021
Q2 | – | Sell |
-17,203
| Closed | -$266K | – | 3826 |
|
|
2021
Q1 | $266K | Buy |
+17,203
| New | +$266K | ﹤0.01% | 2703 |
|
|
2020
Q3 | – | Sell |
-118,574
| Closed | -$1.21M | – | 2848 |
|
|
2020
Q2 | $1.21M | Buy |
+118,574
| New | +$1.21M | ﹤0.01% | 1833 |
|
|
2019
Q3 | – | Sell |
-4,579
| Closed | -$76K | – | 2810 |
|
|
2019
Q2 | $76K | Buy |
+4,579
| New | +$76K | ﹤0.01% | 2504 |
|